ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1716

Poor-Prognosis Factors of Systemic Vasculitides with Gastrointestinal Involvement: Data from a Large Retrospective Study

Segolene Gendreau1, Benjamin Thoreau 2, François Maurier 3, Tiphaine Goulenok 1, Laure Frumholtz 1, Arsène Mékinian 4, Saskia Oro 5, Charlotte Bernigaud 5, Alexandra Audemard 1, Maxime Samson 6, Antoine Gaillet 1, Romain Sonneville 1, Jean-Benoit Arlet 1, Adrien Mirouse 1, Jean-Emmanuel Kahn 7, Aurélie Hummel 1, Thomas Pires 8, Wendy Jourde 8, Eric Hachulla 9, Pierre-Louis Carron 10, Cécile-Audrey Durel 11, Francoise Sarrot-Reynauld 12, Nathalie Tieulie 13, Elisabeth Diot 14, Christian Agard 15, Guillaume Armengol 16, Alice Berezne 17, Christophe Deligny 18, Fleur Cohen 1, Stanislas Faguer 19, Guillaume Le Guenno 20, Mohamed Hamidou 15, Loïc Guillevin 21 and Benjamin Terrier 21, 1APHP, Paris, France, 2CHU Tours, Tours, France, 3Service de Médecine Interne, Hôpital Belle Isle, Metz, Metz, France, 4Hôpital Saint-Antoine, APHP, Paris, Paris, France, 5APHP, Creteil, France, 6Service de Médecine Interne et Immunologie Clinique, CHU Dijon Bourgogne, Hôpital François Mitterrand, Dijon ; Université Bourgogne-Franche Comté, INSERM, EFS BFC, UMR1098, F-21000 Dijon, Dijon, France, 7APHP, Boulogne Billancourt, France, 8CHU Bordeaux, Bordeaux, France, 9CHU Lille, Lille, France, 10Grenoble, Grenoble, France, 11Department of Internal Medicine, Hôpital Edouard Herriot, Lyon, France, Lyon, France, 12CHU Grenoble, Grenoble, France, 13University Hospital of Nice, Nice, France, 14APHP, Tours, France, 15CHU Nantes, Nantes, France, 16CHU Rouen, Rouen, France, 17CH Annecy Genevois, Annecy, France, 18CHU Martinique, Fort de France, France, 19CHU Toulouse, Toulouse, France, 20CHU Clermont Ferrand, Clermont Ferrand, France, 21National Referral Center for Rare Systemic Autoimmune Diseases Paris Cochin, Paris, France

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: gastrointestinal and prognostic factors, systemic necrotizing vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 11, 2019

Title: Vasculitis – Non-ANCA-Associated & Related Disorders Poster III: Behçet’s Disease & Other Vasculitides

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Gastrointestinal (GI) involvement was described as a poor-prognosis factor of systemic necrotizing vasculitides. However, the prognostic impact of GI involvement may vary according to clinical manifestation and vasculitis subtype. We aimed to describe initial symptoms and outcomes of GI involvement of vasculitides and identify factors predictive of poor outcomes among systemic vasculitides.

Methods: Patients with systemic vasculitides as defined by the 2012 Chapel Hill Consensus Conference and with initial GI involvement were retrospectively included. Baseline characteristics, treatments received and outcomeswere recorded. The primary endpoint was a composite of intensive care unit (ICU) admission, emergency surgical procedure, GI-related sepsis or death.

Results: Among the 191 patients diagnosed between 2006 and 2019 included (67% men, mean±SD age 50±19 years), vasculitides were distributed as follows: 75 IgA vasculitis, 50 ANCA-associated vasculitis, 35 polyarteritis nodosa (PAN), 9 large-vessel vasculitis and 22 other vasculitides (including Behçet’s disease). Seventy-four (39%) patients reached the composite primary endpoint after a median [IQR] of 10 [0–32] days.Sixty (31%) patients were admitted to the ICU, 34 (18%) required emergency surgery, 30 (16%) had GI-related sepsis. Twelve (6%) patients died of a GI cause after a median of 41 [24–68] days. Vasculitis subtype was associated with the primary endpoint: PAN diagnosis was associated with a poor outcome (hazards ratio [HR] 2.21 (95% CI 1.36–3.62); P< 0.001), while IgA vasculitis had a better outcome (HR 0.32 (95% CI 0.18–0.58); P< 0.001).
Baseline characteristics associated with the primary endpoint [HR (95% CI)] included: age [1.02 (1.0–1.03); P=0.007], fever [2.52 (1.56–4.08); P< 0.001], abdominal pain requiring morphine [3.05 (1.74–5.34); P< 0.001], abdominal guarding [2.76 (1.53–4.98); P=0.001], ileus [3.1 (1.79–5.36); P=0.001], melena [2.30 (1.33–3.98); P=0.003]and intestinal ischemia [3.95 (2.14–7.28); P< 0.001]. High serum C-reactive protein level, WBC count, lactate dehydrogenase levels, performance status, in-hospital admission SOFA score, low oxygen saturation, and hemoglobin and bicarbonate levels were associated with poor outcomes. Endoscopy-identified mucosal abnormalities were not associated with the primary outcome.
To identify patients requiring ICU admission, emergency surgery, GI-related sepsis or death, a score predictive of poor outcome is being developed.

Conclusion: Vasculitides with initial GI involvement, mainly PAN, had poor outcomes for >30% of the patients. We identified a set of clinical and biological factors present at diagnosis associated with this poor outcome. We are devising a predictive score based on these variables to identify patients requiring early supportive care.


Disclosure: S. Gendreau, None; B. Thoreau, None; F. Maurier, None; T. Goulenok, None; L. Frumholtz, None; A. Mékinian, None; S. Oro, None; C. Bernigaud, None; A. Audemard, None; M. Samson, None; A. Gaillet, None; R. Sonneville, None; J. Arlet, None; A. Mirouse, None; J. Kahn, None; A. Hummel, None; T. Pires, None; W. Jourde, None; E. Hachulla, None; P. Carron, None; C. Durel, None; F. Sarrot-Reynauld, None; N. Tieulie, None; E. Diot, None; C. Agard, None; G. Armengol, None; A. Berezne, None; C. Deligny, None; F. Cohen, None; S. Faguer, None; G. Le Guenno, None; M. Hamidou, Roche, 8; L. Guillevin, None; B. Terrier, Grifols, 8, GSK, 8, LFB, 8, Roche, 8.

To cite this abstract in AMA style:

Gendreau S, Thoreau B, Maurier F, Goulenok T, Frumholtz L, Mékinian A, Oro S, Bernigaud C, Audemard A, Samson M, Gaillet A, Sonneville R, Arlet J, Mirouse A, Kahn J, Hummel A, Pires T, Jourde W, Hachulla E, Carron P, Durel C, Sarrot-Reynauld F, Tieulie N, Diot E, Agard C, Armengol G, Berezne A, Deligny C, Cohen F, Faguer S, Le Guenno G, Hamidou M, Guillevin L, Terrier B. Poor-Prognosis Factors of Systemic Vasculitides with Gastrointestinal Involvement: Data from a Large Retrospective Study [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/poor-prognosis-factors-of-systemic-vasculitides-with-gastrointestinal-involvement-data-from-a-large-retrospective-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/poor-prognosis-factors-of-systemic-vasculitides-with-gastrointestinal-involvement-data-from-a-large-retrospective-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology